CATHERINE MUNICA: Open Payments
NPI 1336746825 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 7 payments from 7 companies in 2025. Trend: 2023 $225 · 2024 $798 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $150 |
| Amgen Inc. | 1 | $140 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Boston Scientific Corporation | 1 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $106 |
| Neurocrine BioSciences, Inc. | 1 | $85 |
| E.R. Squibb & Sons, L.L.C. | 1 | $81 |
Products named: Livdelzi, KRYSTEXXA, VOQUEZNA, WATCHMAN FLX, Kerendia, INGREZZA, CAMZYOS.
Industry payments across TX — which companies pay providers there.
